In spite of the emerging importance of FASN as a marker of tumor aggressiveness [11], a possible pharmacological target [31,32], and a prognostic indicator [11,49], there are no probes for direct in vivo PET imaging of FASN expression. The gene discussed is FASN; the disease is neoplasm.